NCT04764006 2021-11-04Surufatinib Combined With Sintilimab for Advanced MSS-Type Colorectal Cancer : a Phase II StudyFujian Cancer HospitalPhase 2 Unknown10 enrolled
NCT04929652 2021-06-18Surufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal CancerJiangsu Cancer Institute & HospitalPhase 1/2 Unknown48 enrolled